Safety of hydroxychloroquine for treatment or prevention of SARS‐CoV‐2 infection: A rapid systematic review and meta‐analysis of randomized clinical trials,Immunity, Inflammation and Disease

当前位置： X-MOL 学术 › Immun. Inflamm. Dis. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Safety of hydroxychloroquine for treatment or prevention of SARS‐CoV‐2 infection: A rapid systematic review and meta‐analysis of randomized clinical trials
Immunity, Inflammation and Disease ( IF 3.1 ) Pub Date : 2020-11-26 , DOI: 10.1002/iid3.374
Alberto Enrico Maraolo ₁ , Adriano Grossi ₂

Affiliation

Hydroxycloroquine (HCQ) has been extensively studied for treatment and prevention of coronavirus diseases 2019 (COVID‐19) from the start of the pandemic. Conflicting evidence about its usefulness has begun to accrue.

中文翻译：